Functional 20s proteasomes in mature human red blood cells

Experimental Biology and Medicine

Volumn 236, Issue 5, 2011, Pages 580-591

  Neelam, Sudha ^a   Kakhniashvili, David G ^a   Wilkens, Stephan ^a   Levene, Stephen D ^b   Goodman, Steven R ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

2d dige; Atomic force microscopy; Electron microscopy; Erythrocytes; Proteasomes; Proteolysis; Proteomics

Indexed keywords

LACTACYSTIN; MEMBRANE PROTEIN; PROTEASOME;

ARTICLE; ATOMIC FORCE MICROSCOPY; CELL MATURATION; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOREACTIVITY; IN VITRO STUDY; LEUKOCYTE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEOMICS; RETICULOCYTE; TRANSMISSION ELECTRON MICROSCOPY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ACETYLCYSTEINE; BLOOD PROTEINS; CELL DIFFERENTIATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ERYTHROCYTES; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MEMBRANE PROTEINS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, CONFOCAL; PROTEASOME ENDOPEPTIDASE COMPLEX; SUBCELLULAR FRACTIONS;

EID: 79958796521     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.010394     Document Type: Article

References (37)

1. Etlinger JD, Goldberg AL. A soluble ATP-dependent proteolytic system responsible for degradation of abnormal proteins in reticulocytes. Proc Natl Acad Sci USA 1977;74:54-58
2. Speiser S, Etlinger JD. Loss of ATP-dependent proteolysis with maturation of reticulocytes and erythrocytes. J Biol Chem 1982;257:14122-14127
3. Fagan JM, Waxman L, Goldberg AL. Red blood cells contain a pathway for the degradation of oxidant-damaged hemoglobin that does not require ATP or ubiquitin. J Biol Chem 1986;261:5705-5713
4. Pickart CM, Vella AT. Levels of active ubiquitin carrier proteins decline during erythroid maturation. J Biol Chem 1988;263:12028-12035
5. Haas AL, Bright PM. The immunochemical detection and quantitation of intracellular ubiquitin-protein conjugates. J Biol Chem 1985;260:12464-12473
6. Chang TL, Kakhniashvili DG, Goodman SR. Spectrin's E2/E3 ubiquitin conjugating/ligating activity is diminished in sickle cells. Am J Hematol 2005;79:89-96
7. Kakhniashvili DG, Chaudhary T, Zimmer WE, Bencsath FA, Jardine I, Goodman SR. Erythrocyte spectrin is an E2 ubiquitin conjugatingenzyme. Biochemistry 2001;40:11630-11642
8. Hsu YJ, Goodman SR. Spectrin and ubiquitination: a review. Cell Mol Biol (Noisy-le-grand, France) 2005;Suppl. 51:OL801-OL807
9. Chang TL, Cubillos FF, Kakhniashvili DG, Goodman SR. Band 3 is a target protein of spectrin's E2/E3 activity: implication for sickle cell disease and normal red blood cell aging. Cell Mol Biol 2004;50:171-177
10. Chang TL, Cubillos FF, Kakhniashvili DG, Goodman SR. Ankyrin is a target of spectrin's E2/E3 ubiquitin-conjugating/ligating activity. Cell Mol Biol 2004;50:59-66
11. Low TY, Seow TK, Chung MC. Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2002;2:1229-1239
12. Kakhniashvili DG, Bulla LA Jr, Goodman SR. The human erythrocyte proteome: analysis by ion trap mass spectrometry. Mol Cell Proteom 2004;3:501-509
13. Pasini EM, Kirkegaard M, Mortensen P, Lutz HU, Thomas AW, Mann M. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 2006;108:791-801
14. Goodman SR, Kurdia A, Ammann L, Kakhniashvili DG, Daescu O. The human red blood cell proteome and interactome. Exp Biol Med 2007;232:1391-408
15. Ghatpande SS, Choudhary PK, Quinn CT, Goodman SR. In vivo pharmaco-proteomic analysis of hydroxyurea induced changes in the sickle red blood cell membrane proteome. J Proteom 2010;73:619-626
16. Goodman SR, Hughes KM, Kakhniashvili DG, Neelam S. The isolation of reticulocyte-free human red blood cells. Exp Biol Med 2007;232:1470-1476
17. Shibatani T, Carlson EJ, Larabee F, McCormack AL, Frú K, Skach WR. Global organization and function of mammalian cytosolic proteasome pools. Mol Biol Cell 2006;17:4962-4971
18. Rivett AJ, Bose S, Pemberton AJ, Brooks P, Onion D, Shirley D, Stratford FL, Forti K. Assays of proteasome activity in relation to aging. Exp Gerontol 2002;37:1217-1222
19. Kienberger F, Pastushenko VP, Kada G, Puntheeranurak T, Chtcheglova L, Riethmueller C, Rankl C, Ebner A, Hinterdorfer P. Improving the contrast of topographical AFM images by a simple averaging filter. Ultramicroscopy 2006;106:822-8228
20. Ludtke SJ, Baldwin PR, Chiu W. EMAN: semiautomated software for high-resolution single-particle reconstructions. J Struct Biol 1999;128:82-97
21. Van Heel M, Harauz G, Orlova EV, Schmidt R, Schatz M. A new generation of the IMAGIC image processing system. 1996;116:17-24
22. Kastner B, Fishen N, Golas MM, Sander B, Dube P, Boehringer D, Hartmuth K, Deckert J, Hauer F, Wolf E, Uchtenhagen H, Urlaub H, Herzag F, Peters JM, Poerschke D, Luhrmann R, Stark H. GraFix: sample preparation for single-particle electron cryomicroscopy. Nat Methods 2008;5:53-5
23. Bochtler M, Ditzel L, Groll M, Hartmann C, Huber R. The Proteaosme. Annu Rev Biophys Biomol Struct 1999;28:295-317
24. Drews O, Wildgruber R, Zong C, Sukop U, Nissum M, Weber G, Gomes AV, Ping P. Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities. Mol Cell Proteom 2007;6:2010-2031
25. Cascio P, Call M, Pete BM, Walz T, Goldberg AL. Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes. EMBO J 2002;21:2636-2645
26. Kim AY, Bommeljé CC, Lee BE, Yonekawa Y, Choi L, Morris LG, Huang G, Kaufman A, Ryan RJ, Hao B, Ramanathan Y, Singh B. SCCRO (DCUN1D1) is an essential component of the E3 complex for neddylation. J Biol Chem 2008;283:33211-33220
27. Chen Y, Gan BQ, Tang BL. Syntaxin 16: unraveling cellular physiology through a ubiquitous SNARE molecule. J Cell Physiol 2010;225:326-332
28. Damonte G, Guida L, Sdraffa A, Benatti U, Melloni E, Forteleoni G, Meloni T, Carafoli E, De Flora A. Mechanisms of perturbation of erythrocyte calcium homeostasis in favism. Cell Calcium 1992;13:649-658
29. Kim JA, Stevens RC, Maccoss MJ, Goodlett DR, Scherl A, Richter RJ, Suzuki SM, Furlong CE. Identification and characterization of biomarkers of organophosphorus exposures in humans. Adv Exp Med Biol 2010;660:61-71
30. Osna NA, White RL, Donohue TM Jr, Beard MR, Tuma DJ, Kharbanda KK. Impaired methylation as a novel mechanism for proteasome suppression in liver cells. Biochem Biophys Res Commun 2010;391:1291-1296
31. Ogris E, Du X, Nelson KC, Mak EK, Yu XX, Lane WS, Pallas DC. A protein phosphatase methylesterase (PME-1) is one of several novel proteins stably associating with two inactive mutants of protein phosphatase 2A. J Biol Chem 1999;274:14382-14391
32. Reinheckel T, Ullrich O, Sitte N, Grune T. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch Biochem Biophys 2000;377:65-68
33. Davies JA. Degradation of oxidized proteins by the 20S proteasome. Biochimie 2001;83:301-310
34. Tanahashi N, Murakami Y, Minami Y, Shimbara N, Hendil KB, Tanaka K. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J Biol Chem 2000;275:14336-14345
35. Goldberg AL, Boches FS. Oxidized proteins in erythrocytes are rapidly degraded by the adenosine triphosphate-dependent proteolytic system. Science 1982;215:1107-1009
36. Dudel EJ, Shang F, Valverde P, Liu Q, Hobbs M, Taylor A. Selectivity of the ubiquitin pathway for oxidatively modified proteins: relevance to protein precipitation diseases. FASEB J 2005;19:1707-1709
37. Tai HC, Besche H, Goldberg AL, Schuman EM. Characterization of the brain 26S proteasome and its interacting proteins. Front Mol Neurosci 2010;3:1-12